"We observed correlations between time to tumor relapse and the magnitude of changes of proliferation luminal B or HER2-E signatures in metastatic versus primary disease. Although the intrinsic subtype was largely maintained during metastatic progression luminal/HER2-negative tumors acquired a luminal B or HER2-E profile during metastatic progression likely reflecting tumor evolution or acquisition of estrogen independ"xsd:string